Get the Stockscreener App
3.15
1.87%
-0.06
After Hours:
3.02
-0.13
-4.13%
Sonoma Pharmaceuticals Inc stock is traded at $3.15, with a volume of 70,585.
It is down -1.87% in the last 24 hours and up +47.20% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.21
Open:
$3.21
24h Volume:
70,585
Relative Volume:
0.03
Market Cap:
$5.46M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-3.3511
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-6.80%
1M Performance:
+47.20%
6M Performance:
+12.50%
1Y Performance:
+1.68%
1-Day Range:
$3.01
$3.27
1-Week Range:
$3.01
$3.50
52-Week Range:
$1.75
$9.374
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.15 | 5.46M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement - knoxdaily.com
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Stocks of Sonoma Pharmaceuticals Inc (SNOA) are poised to climb above their peers - Sete News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Financial Analysis: Integra Resources Corp (ITRG)’s Ratios Unveil Key Insights - DWinneX
Metric Deep Dive: Understanding Sonoma Pharmaceuticals Inc (SNOA) Through its Ratios - DWinneX
Analyzing SNOA’s price-to-book ratio for the last quarter - uspostnews.com
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Sonoma Pharmaceuticals Inc (SNOA) Stock: A Year of Declines and Increases - investchronicle.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX
UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock - The Globe and Mail
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket - marketscreener.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals (SNOA) Expands Reach with UK Product Regi - GuruFocus
Major UK Retail Breakthrough: Sonoma's Natural Acne Treatment to Roll Out Across 1,200 Leading Pharmacies - Stock Titan
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $315.58 - Defense World
NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World
Rising Trends of Scar Treatment Market in Worldwide | Top most Key - openPR.com
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
SNOA stock touches 52-week low at $1.84 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $1.84 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Delaware passes law designed to stop more Elon Musks from leaving state - Yahoo Finance
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain - Yahoo Finance
Sonoma Pharmaceuticals expands agreement with WellSpring By Investing.com - Investing.com Australia
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
Sonoma Pharmaceuticals expands agreement with WellSpring - Investing.com
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph
Breakthrough Approval Sends Monogram Technologies (MGRM) Shares Soaring - Stocks Telegraph
Sonoma Pharmaceuticals (SNOA) Gains In Pre-Hour Trading - Stocks Telegraph
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
Scar Management Market Top PlayersNewmedical Technology - openPR.com
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors - Yahoo Finance
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
SNOA's Wound Care Products Get Regulatory Clearance, LFMD's Q4 Revenue Soars, ATRA On Watch - RTTNews
Sonoma Pharmaceuticals expands into UK market By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals expands into UK market - Investing.com India
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 25% Lower - Simply Wall St
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):